Changes of plasma levels of gastrointestinal peptides over the course of acute pancreatitis. Any significance for the pathophysiology and treatment of acute pancreatitis

Background/Aims: Acute pancreatis may be accompanied by alterations of the secretion of pancreatic and gastrointestinal peptides as a result of pancreatic inflammation. These changes, that may constitute targets of therapeutic manipulation, led to study of the serum levels of various pancreatic and gastrointestinal peptides over the course of acute pancreatis before and after the administration of octreotide and ranitidine. Methodology: Concentrations of gastrin, glucagon, vasoactive intestinal peptide, neurotensin and pancreatic polypetide were determined by radioimmunoassay in the plasma of 22 patients with acute pancreatitis on the first, sixt and 11th day of the disease. All patients were treated with octreotide s.c. while 14 of them were also administered ranitidine i.v. Treatment was initiated after taking the first blood sample. Results: Mean gastrin levels in patients receiving ranitidine was 56.76ng/L and in patients not receiving ranitidine 47.16ng/L on the first day (pNS) remaining stable throughout the course of acute pancreatitis. Mean glucagon, vasoactive intestinal peptide, neurotensin and pancreatic polypeptide levels on the first day were 52.05pmol/L, 8.90pmol/L 9.80pmol/L and 22.06pmol/L, respectively, and no changes were found through the course of acute pancreatitis. Conclusions: Plasma levels of gastrointestinal peptides remain constant over time and they are not significantly affected by the administation of octreotide or ranitidine. However more studies are necessary to document the significance of these findings.